SXTP logo

SXTP

Profile

Full Name

60 Degrees Pharmaceuticals, Inc.

Ticker Symbol

SXTP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 12, 2023

Indexes

Not included

Website

http://www.60degreespharma.com

Employees

3

Key Details

Price

$3.16(-0.32%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$607.60K(+139.59% YoY)

Annual EPS

-$18.55(+68.65% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.16
SXTP price is $3.16

30-Day Relative Volume

0.02
SXTP 30-day relative volume is 0.02

Price Performance

Price Most recent change

-0.32%
SXTP price was down -0.32% on Apr 17, 2025

Price YTD change

-51.01%
SXTP price is down -51.01% since January 1st

Price 1-year change

-79.1%
SXTP price is down -79.1% year-on-year

Price 3-year change

-
SXTP price 3-year change is unknown

Price Range

Price All-time high

$519.00
SXTP price is currently -99.39% below its historical high of $519.00

Price 3-year low

$1.41
SXTP price is currently +124.11% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.65M
SXTP market capitalization is $4.65 million

Market cap 3-year change

-
SXTP market capitalization 3-year change is unknown

Market cap All-time high

$26.06M
SXTP market capitalization is currently -82.14% below its historical high of $26.06 million

Market cap sector rank

12.76%
SXTP market capitalization is higher than 12.76% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+663.95%
SXTP shares outstanding is up +663.95% year-on-year

Shares Outstanding 3-Year Change

-
SXTP shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.54
SXTP beta is -0.54

200-day SMA

$5.74
SXTP price is currently -44.91% below its 200-day simple moving average

50-day SMA

$2.23
SXTP price is currently +41.43% above its 50-day simple moving average

RSI

63.19
SXTP 14-day relative strength index is 63.19

Volume

0.02
SXTP 30-day relative volume is 0.02

ATR

$0.46
SXTP average true range is $0.46

10-day Historical Volatility

335.72%
SXTP 10-day historical volatility is 335.72%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$607.60K
SXTP annual revenue is $607.60 thousand

Revenue Analysts estimate

$1.61M
SXTP annual revenue is currently -62.30% lower than the consensus analysts' forecast

Revenue 1-year change

+139.59%
SXTP annual revenue is up +139.59% year-on-year

Revenue Sector rank

10.65%
SXTP annual revenue is higher than 10.65% of companies in Healthcare sector

EPS

EPS

-$18.55
SXTP annual earnings per share is -$18.55

EPS Analysts estimate

-$5.32
SXTP annual earnings per share is currently +248.68% higher than the consensus analysts' forecast

EPS 1-year change

+68.65%
SXTP annual earnings per share is up +68.65% year-on-year

EPS Sector rank

7.87%
SXTP annual earnings per share is higher than 7.87% of companies in Healthcare sector

Profit

Gross profit

$222.80K
SXTP annual gross profit is $222.80 thousand

Gross margin

36.67%
SXTP annual gross profit margin is 36.67%

Operating profit

-$9.71M
SXTP annual operating income is -$9.71 million

Operating margin

-1598.97%
SXTP annual operating profit margin is -1598.97%

Net income

-$7.95M
SXTP annual net profit is -$7.95 million

Net margin

-1308.01%
SXTP annual net profit margin is -1308.01%

Expenses

Total expenses

$10.32M
SXTP annual total expenses is $10.32 million

Operating expenses

$9.94M
SXTP annual total operating expenses is $9.94 million

Cost of goods sold

$384.80K
SXTP annual cost of goods sold is $384.80 thousand

Selling, general & administrative expenses

$5.03M
SXTP annual SGA is $5.03 million

Depreciation and amortization

$63.70K
SXTP annual depreciation & amortization is $63.70 thousand

Interest expense

$7900.00
SXTP annual interest expense is $7900.00

Income tax

$300.00
SXTP annual income tax is $300.00

EBIT & EBITDA

EBIT

-$7.95M
SXTP annual earnings before interest & taxes is -$7.95 million

EBITDA

-$7.88M
SXTP annual EBITDA is -$7.88 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$5.76M
SXTP annual total assets is $5.76 million

Non current assets

$373.10K
SXTP annual long term assets is $373.10 thousand

Current assets

$5.39M
SXTP annual total current assets is $5.39 million

Cash and cash equivalents

$1.66M
SXTP annual cash & cash equivalents is $1.66 million

Accounts receivable

$486.70K
SXTP annual accounts receivable is $486.70 thousand

Inventory

$442.80K
SXTP annual inventory is $442.80 thousand

Liabilities

Total liabilities

$1.80M
SXTP annual total liabilities is $1.80 million

Long term liabilities

$147.10K
SXTP annual total long term liabilities is $147.10 thousand

Current liabilities

$1.66M
SXTP annual total current liabilities is $1.66 million

Accounts payable

$1.01M
SXTP annual accounts payable is $1.01 million

Debt

Total debt

$155.90K
SXTP annual total debt is $155.90 thousand

Total debt 1-year change

-9.73%
SXTP annual total debt is down -9.73% year-on-year

Long term debt

$147.10K
SXTP annual long term debt is $147.10 thousand

Short term debt

$8800.00
SXTP annual short term debt is $8800.00

Equity & Capital

Shareholders equity

$4.04M
SXTP annual stockholders equity is $4.04 million

Book value

-$5.53M
SXTP annual book value is -$5.53 million

Retained earnings

-$40.53M
SXTP annual retained earnings is -$40.53 million

Working capital

$3.73M
SXTP annual working capital is $3.73 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$5.65M
SXTP annual cash flow from operations is -$5.65 million

Cash from operations 1-year change

-24.33%
SXTP annual cash flow from operations is down -24.33% year-on-year

Cash from investing

-$1.89M
SXTP annual cash flow from investing activities is -$1.89 million

Cash from investing 1-year change

-1529.94%
SXTP annual cash flow from investing activities is down -1529.94% year-on-year

Cash from financing

$7.05M
SXTP annual cash flow from financing activities is $7.05 million

Cash from financing 1-year change

+8.94%
SXTP annual cash flow from financing activities is up +8.94% year-on-year

CAPEX

CAPEX

$181.10K
SXTP annual capital expenditures is $181.10 thousand

CAPEX 1-year change

+56.26%
SXTP annual capital expenditures is up +56.26% year-on-year

Free Cash Flow

Free cash flow

-$5.83M
SXTP annual free cash flow is -$5.83 million

Free cash flow 1-year change

-25.12%
SXTP annual free cash flow is down -25.12% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

36.67%
SXTP annual gross profit margin is 36.67%

Operating margin

-1598.97%
SXTP annual operating profit margin is -1598.97%

Net margin

-1308.01%
SXTP annual net profit margin is -1308.01%

ROA & ROE

ROA

-117.36%
SXTP annual return on assets is -117.36%

ROE

-181.58%
SXTP annual return on equity is -181.58%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SXTP price to earnings ratio value is unknown

PE ratio Sector rank

-
SXTP price to earnings ratio is unknown

PB Ratio

PB ratio

-0.84
SXTP price to book ratio is -0.84

PB ratio Sector rank

9.32%
SXTP price to book ratio is higher than 9.32% of companies in Healthcare sector

PS Ratio

PS ratio

7.66
SXTP price to sales ratio is 7.66

PS ratio Sector rank

74.84%
SXTP price to sales ratio is higher than 74.84% of companies in Healthcare sector

Enterprise value

Enterprise value

$3.15M
SXTP enterprise value is $3.15 million

Enterprise value Sector rank

16.36%
SXTP enterprise value is higher than 16.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.40
SXTP EV/EBITDA is -0.40

EV/EBITDA Sector rank

53.61%
SXTP EV/EBITDA is higher than 53.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.25
SXTP annual current ratio is 3.25

Quick ratio

2.98
SXTP annual quick ratio is 2.98

Leverage

Debt to equity

0.04
SXTP annual debt to equity ratio is 0.04

Interest coverage ratio

-1006.01
SXTP annual interest coverage ratio is -1006.01

Risk & Stability

Piotroski F-Score

5
SXTP piotroski f-score is 5

Altman Z-Score

-11.98
SXTP altman z-score is -11.98

Analyst ratings

Recent major analysts updates

Mar 28, 25 HC Wainwright & Co.
Neutral
Feb 25, 25 HC Wainwright & Co.
Neutral
Jan 10, 25 HC Wainwright & Co.
Neutral
Dec 23, 24 HC Wainwright & Co.
Neutral
Dec 11, 24 HC Wainwright & Co.
Neutral
Nov 15, 24 HC Wainwright & Co.
Neutral
Sep 13, 24 HC Wainwright & Co.
Neutral
Aug 15, 24 HC Wainwright & Co.
Neutral
Jun 6, 24 HC Wainwright & Co.
Neutral
Apr 3, 24 HC Wainwright & Co.
Neutral

Institutional Ownership

Similar stocks

APM logo
Aptorum Group Limited (APM)
AMIX logo
Autonomix Medical (AMIX)
IMCC logo
IM Cannabis (IMCC)
SBFM logo
Sunshine Biopharma (SBFM)
ADIL logo
Adial Pharmaceuticals (ADIL)
SILO logo
Silo Pharma (SILO)
Klotho Neurosciences (KLTO)
IBO logo
Impact BioMedical (IBO)
ALZN logo
Alzamend Neuro (ALZN)
  • What is the ticker symbol for 60 Degrees Pharmaceuticals?
  • Does 60 Degrees Pharmaceuticals pay dividends?
  • What sector is 60 Degrees Pharmaceuticals in?
  • What industry is 60 Degrees Pharmaceuticals in?
  • What country is 60 Degrees Pharmaceuticals based in?
  • When did 60 Degrees Pharmaceuticals go public?
  • Is 60 Degrees Pharmaceuticals in the S&P 500?
  • Is 60 Degrees Pharmaceuticals in the NASDAQ 100?
  • Is 60 Degrees Pharmaceuticals in the Dow Jones?
  • When does 60 Degrees Pharmaceuticals report earnings?
  • Should I buy 60 Degrees Pharmaceuticals stock now?

What is the ticker symbol for 60 Degrees Pharmaceuticals?

The ticker symbol for 60 Degrees Pharmaceuticals is NASDAQ:SXTP

Does 60 Degrees Pharmaceuticals pay dividends?

No, 60 Degrees Pharmaceuticals does not pay dividends

What sector is 60 Degrees Pharmaceuticals in?

60 Degrees Pharmaceuticals is in the Healthcare sector

What industry is 60 Degrees Pharmaceuticals in?

60 Degrees Pharmaceuticals is in the Biotechnology industry

What country is 60 Degrees Pharmaceuticals based in?

60 Degrees Pharmaceuticals is headquartered in United States

When did 60 Degrees Pharmaceuticals go public?

60 Degrees Pharmaceuticals's initial public offering (IPO) was on July 12, 2023

Is 60 Degrees Pharmaceuticals in the S&P 500?

No, 60 Degrees Pharmaceuticals is not included in the S&P 500 index

Is 60 Degrees Pharmaceuticals in the NASDAQ 100?

No, 60 Degrees Pharmaceuticals is not included in the NASDAQ 100 index

Is 60 Degrees Pharmaceuticals in the Dow Jones?

No, 60 Degrees Pharmaceuticals is not included in the Dow Jones index

When does 60 Degrees Pharmaceuticals report earnings?

The date for 60 Degrees Pharmaceuticals's next earnings report has not been announced yet

Should I buy 60 Degrees Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page